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Objective: To understand Australian hospital
pharmacists’ accounts of antibiotic use, and the
potential role of pharmacy in antibiotic optimisation
within a tertiary hospital setting.
Design, setting and participants: Qualitative study,
utilising semistructured interviews with 19 pharmacists
in two hospitals in Queensland, Australia in 2014. Data
was analysed using the framework approach and
supported by NVivo10 qualitative data analysis
software.
Results: The results demonstrate that (1)
pharmacists’ attitudes are ambivalent towards the
significance of antibiotic resistance with optimising
antibiotic use perceived as low priority; (2)
pharmacists’ current capacity to influence antibiotic
decision-making is limited by the prescribing power of
doctors and the perception of antibiotic use as a
medical responsibility; and, (3) interprofessional and
organisational barriers exist that prevent change in the
hospital setting including medical hierarchies, limited
contact with senior doctors and resource constraints
resulting in insufficient pharmacy staffing to foster
collaborative relationships and facilitate the uptake of
their advice.
Discussion: While pharmacy is playing an
increasingly important role in enhanced antibiotic
governance and is a vital component of antimicrobial
stewardship in Australia, role-based limitations,
interprofessional dynamics and organisational/resource
constraints in hospitals, if not urgently addressed, will
continue to significantly limit the ability of pharmacy to
influence antibiotic prescribing.
INTRODUCTION
Suboptimal prescribing of antibiotics in
Australian hospitals is common1 despite the
rollout of antimicrobial stewardship (AMS)
programmes nationally. Around 50% of hos-
pital inpatients in Australia will receive an
antibiotic and the 2013 National
Antimicrobial Prescribing Survey of 151
Australian hospitals recorded that 22.9% of
these antibiotic prescriptions were inappro-
priate.2 3 Studies internationally illustrate
similar trends.4 5 There is considerable
concern around the relationship between
antibiotic overuse and escalating antimicro-
bial resistance,6 7 and thus optimising anti-
biotic use across healthcare sectors remains a
key component of global and local efforts to
protect antibiotic options for the future and
curb the escalation of resistant organisms.8
Suboptimal use of antibiotics has previ-
ously been conceived as largely a medical
issue given doctors are the prescribers.9 Yet,
infection management and antibiotic deci-
sions are team-based, and interprofessional
in nature.10 In many Australian hospitals,
decisions about antibiotics involve input
from pharmacists, as well as infectious dis-
eases specialists. The expansion of AMS pro-
grammes in Australia has increased the
collaborative nature of antibiotic decision-
making, formalising the role of pharmacists
in many settings as advisors in attempts to
improve prescribing.11 12
Optimising antimicrobial use within hospi-
tals is now a legislative requirement in many
countries.13 In Australia, the National Safety
and Quality Health Service Standards
require every hospital to have an effective
AMS programme in place to fulﬁl
Strengths and limitations of this study
▪ Provides depth of insight into the significance of
hospital pharmacy in antibiotic use and
governance.
▪ Examines the perspectives of a core, but often
unrecognised, stakeholder in infection manage-
ment and antibiotic decisions.
▪ Highlights the crucial role played by pharmacists
in negotiating interprofessional dynamics in
hospitals.
▪ Exposes the role-based limitations of pharmacy
input into optimal antibiotic decision-making.
▪ The sample, while appropriate for a qualitative
study, could be expanded in future studies to
incorporate other sites, organisational environ-
ments and professional perspectives.
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accreditation requirements.14 15 Evidence indicates that
AMS programmes are not leading to the level of practice
change and antibiotic optimisation anticipated.1 3
Persistent suboptimal antibiotic use, post roll-out of AMS
programmes, has raised questions around the social and
behavioural drivers of suboptimal antibiotic use16 and
the need for in-depth examination of health profes-
sionals’ experiences of antibiotic decision-making.17
Research drawing on social and behavioural
approaches has illustrated that the character of relation-
ships between doctors can heavily inﬂuence antibiotic
decisions.16 This includes being inﬂuenced by
entrenched localised norms of antibiotic use, profes-
sional hierarchies and the tendency to prioritise short-
term infective risk reduction, rather than the long-term
optimisation of antibiotics.9 Yet, there has been little
research completed on antibiotic use from the perspec-
tive of pharmacists, including their views on barriers to
optimisation.10 18 19 Given the emerging role for phar-
macy in AMS,10 11 this study sought to address this over-
sight. The objective of the study was to investigate
hospital pharmacists’ accounts of antibiotic use, and the
potential role of pharmacy in antibiotic optimisation.
METHODS
This qualitative study was developed to explore pharma-
cists’ experiences of use of antibiotics at two hospitals in
Queensland, Australia. The hospitals are small to
mid-size with approximately 500 beds between them and
are afﬁliated with a university-based clinical school. As is
compulsory in Australia, the participating hospitals have
an AMS in place in which pharmacy is allocated a signiﬁ-
cant role. Pharmacists are actively encouraged to partici-
pate in AMS including referring restricted
antimicrobials to the AMS team. Pharmacy education
sessions have been regularly undertaken to engage phar-
macy in AMS activities.
Data collection and sample
Employing an inductive approach, data was collected
through semistructured interviews with 19 pharmacists.
The study was advertised to all pharmacists working at
each of the two participating hospitals in Queensland,
Australia. Pharmacists expressing an interest in the study
(by responding to the email on a voluntary basis) were
then contacted to arrange a time and place convenient
for an interview and given the information sheet. Over
90% (n=29) of the contacted pharmacists agreed to par-
ticipate. Nineteen of the pharmacists were available
during the scheduled ﬁeldwork days. The researchers
agreed following completion and analysis of the 19 inter-
views that data saturation had been reached—that is, we
had reached the point when no new themes were emer-
ging.20 The sample included a range of early career,
mid-career and senior pharmacists as well a gender split
(12 females and 7 males). All participants were given
ample opportunity to ask questions before consenting to
participate. Each interview lasted between 30 and
60 min, was digitally audio recorded and transcribed in
full by a professional transcribing company. An interview
guide was utilised around the following domains: under-
standing and awareness of issues around antibiotic use
and resistance; role of pharmacy within the hospital;
knowledge and expertise regarding antibiotics; profes-
sional and interprofessional issues; and, governance and
organisational context.
Analysis
NVivo10 software was used to systematically conduct a
thematic content analysis of the full interview transcripts.
The thematic analysis of the data was driven by the
framework approach.20 Independent coding of the data
was provided initially by members of the research team
(AB and EK), which was then cross-checked to facilitate
the development of themes ( JB and SP), moving
towards an overall interpretation of the data. Analytic
rigour was enhanced by searching for negative, atypical
and conﬂicting or contradicting cases in coding and
theme development. Inter-rater reliability was ensured
by integrating a number of research team members in
the ﬁnal analysis (AB, EK and SP), including a clinical
infectious diseases specialist ( JB).
RESULTS
Here we report the themes which emerged from the
analysis of the interviews. It was clear from the interviews
that pharmacists often experience barriers that limit
their ability to inﬂuence antibiotic usage, or enact
change. Our analysis revealed three main themes, which
are summarised in table 1, with indicative examples of
subthemes raised by the participants within the
interviews.
Attitudes towards significance of antibiotic use
in hospitals and the threat of resistance
A key topic within the interviews was the relative signiﬁ-
cance of optimising antibiotic use and antimicrobial
resistance for pharmacists in hospital contexts. The par-
ticipants’ views were inconsistent, reﬂecting considerable
variation across the pharmacists interviewed regarding
improving antibiotic use as a core practice problem.
Approximately half of the participants talked about anti-
biotic use as highly signiﬁcant, with frequent references
to the importance of optimal prescribing, particularly
given increasing rates of resistant organisms:
I think [pharmacists] take [antibiotic use] very seriously.
I think they love to get involved… [Participant #3]
There was however, consensus throughout the inter-
views that awareness of resistance did not translate into
suitable levels of concern on the ward:
I’ve been to a few seminars on [antibiotic resistance],
and you get the dire messages coming out [about
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resistant organisms]. Then you walk back into your own
area of practice and you just see, there doesn’t seem to
be that urgency around it. [Participant #10]
There was a clear perception within the participant
group that optimal antibiotic use and the broader
concept of antibiotic resistance was not a priority in
day-to-day pharmacy work:
I don’t think there’s a very good awareness [of subopti-
mal prescribing]…It’s so easy to get bogged down in the
particular case in front of you and just not think about
the global impact of what decision you’re making has.
[Participant #7]
Another participant responded:
What are you supposed to do [about antibiotics]? There’s
a basic delivery of services which needs to happen and
that is the delivery of medication, and everything else is
extra…you have to ensure that the core service is func-
tional. [Participant #19]
Ultimately, while views were divergent on level of
awareness within pharmacy, there was consistency in the
view that suboptimal antibiotic use and the threat of
enhanced resistance was not a focus of daily activity and
warranted further attention both within and outside
pharmacy.
The capacity of pharmacists to influence antibiotic
decision-making
The second theme emergent from the interviews was
the self-perceived capacity of pharmacy to inﬂuence
antibiotic use within hospitals settings. Discussion within
the interviews included the roles played by pharmacists
and the relative responsibility of pharmacy to
optimise practice. Although the interviews revealed
divergent perspectives as to pharmacy’s level of relative
responsibility for optimising antibiotic use, the majority
of participants citing pharmacy as having limited
responsibility:
We do have a big responsibility to ensure that, with any
drug, that it’s prescribed appropriately and used appro-
priately… pharmacy is really important, but the doctors
do need to take that responsibility when they are pre-
scribing [antibiotics]. [Participant #7]
Another participant responded:
There is some responsibility that lies with me because
you’re assisting in the prescribing process. [Participant #4]
There was signiﬁcant awareness of prescribing as
‘everyone’s’ problem, but in practice, as shown in the
quotes above, antibiotic prescribing was predominantly
deemed a medical responsibility, with pharmacy assist-
ing. That said, approximately half of the participants
talked about their efforts to improve practice. As one
participant said:
I’m really diligent about [about antibiotics], well, I try to
be, about what I can do on charts. [Participant #19]
Participants frequently articulated self-perceived
limited authority to enact change in antibiotic prescrib-
ing. Also identiﬁed was a lack of capacity to convey
advice and expertise in antibiotic use in their current
role, particularly the challenges associated with not
Table 1 Summary of themes
Theme Examples of subthemes
Attitudes towards significance of antibiotic use in
hospitals and the threat of resistance
▸ Divergent views on significance of antibiotic use and resistance for
pharmacy
▸ Optimising antibiotics relatively low priority in day-to-day pharmacy
work
▸ Perception of more urgent areas of practice to enforce practice
change than antibiotics
The capacity of pharmacists to influence antibiotic
decision-making
▸ Divergent perspectives as to pharmacy’s level of responsibility for
optimising antibiotic use
▸ Lack of capacity to enforce best practice given prescribing power of
doctors
▸ Antibiotic use as ‘everyone’s problem’, but in practice a medical
responsibility
▸ Perception of limited authority and lack of capacity to actualise
considerable pharmacy expertise in shaping antibiotic use
Interprofessional and organisational barriers to
enacting change
▸ Medical hierarchies, and limited contact with senior doctors, limit
pharmacists capacity to optimise prescribing
▸ Relationship between doctors and pharmacists needs to shift from
pharmacy as ‘police’ to ‘stewards’ or ‘advisors’
▸ Pharmacy staffing highly significant in shaping relationships and
uptake of advice
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always being ‘at the bedside’ to give advice at the point
of initiation of antibiotics (ie, regarding issues of choice,
dosage, duration and mode of delivery). Despite limited
authority and capacity in their current role, all of the
participants referenced the untapped knowledge and
skills of pharmacy in educating, informing and assisting
medical staff in best-practice decision-making around
antibiotics. A lack of consultation early in the decision-
making process meant that pharmacists were often not
well placed to offer their support around optimising use.
As one participant said:
A lot of the time pharmacists don’t see it [antibiotic pre-
scribing] until after it’s already happened, it’s too late,
there’s not a lot you can do about it. [Participant #1]
Interprofessional and organisational barriers
to enacting change
The ﬁnal theme emergent from the interviews was the
interprofessional and organisational barriers to pharma-
cists contributing to the optimisation of antibiotic use.
This included difﬁculties experienced in managing
the relationship between pharmacy and medicine, and
the delineation of professional territories. All of the
pharmacists recognised the pressures faced by doctors in
decision-making around antibiotic use, and stressed the
challenges involved with intervening in such decisions.
As one participant discussed, issues around ‘face saving’
and concerns around reputation hindered feedback
from pharmacist to doctor:
You’re dealing with people who prescribe and as you as a
non-prescriber are asking them to come on board, you’re
needing to move them [doctors], and you can’t move
them in front of each other because there’s too much at
stake. [Participant #5]
The majority of participants talked about the necessity
for doctors to drive change given their authority in
terms of decision-making. As one participant noted:
They’re [medical staff are] prescribers after all, when
we’re just down the food chain. [Participant #11]
When asked who owns the prescribing decision for an
antibiotic, a participant responded:
I’m not a prescriber…
Interviewer: …who owns the decision, do you know what
I mean? Like when an antibiotic gets to a patient…?
I think if the pharmacist has reviewed it on the ward,
well, then yes, I think some responsibility…But…more of
that responsibility still has to fall with the doctor who is
still actually prescribing it…I’m not trying to say that it’s
all them… [Participant #1]
The interaction of pharmacy with junior medical staff
(rather than senior doctors) regarding antibiotics was
also viewed as a key interprofessional problem, with
junior doctors perceived by pharmacy as highly uncer-
tain regarding optimal use, resulting in a lack of capacity
of pharmacists (and junior doctors) to question anti-
biotic decisions:
[A problem is the] junior doctors are writing [the pre-
scription], but they’re being told by someone else what
to do…it’s not really a lot of times based on therapeutic
guidelines and evidence…if you question “why are you
prescribing this?” [They’ll say] “well, that’s what I was
told to do”…I guess it’s just a culture, just a prescribing
culture. [Participant #1]
Organisational and resourcing factors were perceived
as impeding pharmacy’s contribution to improvement in
antibiotic prescribing practice, predominantly through
limiting the capacity of pharmacy to contribute in real-
time antibiotic decisions at the bedside. For example,
one participant said:
The [pharmacy staff] allocation is probably insufﬁcient
because [and]…they’re actually not there at the begin-
ning of the patient journey, which is the [antibiotic] pre-
scribing…And then they become almost the [antibiotic]
policeman [sic]. [Participant #9]
The majority of participants discussed the need for
enhanced organisational support for pharmacy to assist
in day-to-day improvements in antibiotic practice:
It would have to be policy makers that drive [prescribing
improvement]. Because doctors won’t inherently be con-
cerned, they’re more interested in lots of other things,
treating their patient….I think it just has to be some-
where high up. [Participant #11]
Recent organisational changes such as the appoint-
ment of an AMS pharmacist within the hospital, were
viewed positively in going some way to improving pre-
scribing practice.
I ﬁnd it very helpful [to have an AMS pharmacist]
because if you have an issue with something, like any-
thing that needs ID approval often you’re like “oh, I
don’t know if they really should be using this.” And it
takes that pressure away from you and it means that it’s
actually getting looked at. [Participant #1]
It was clear from the interviews that pharmacy stafﬁng
was highly signiﬁcant in shaping interprofessional rela-
tionships and the delivery of expertise within the hos-
pital. Medical staff were viewed ‘owning’ the antibiotic
prescribing decision and as central to enacting and
shaping change, with acknowledgement by the majority
of participants of the pressure experienced by doctors
and the need for organisational support to facilitate
timely ‘at the bedside’ advice-giving, and team-based
approaches to improving prescribing practice.
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DISCUSSION
This study provides important insights into the experi-
ences of pharmacists in decisions about antibiotics within
the hospital sector. This reinforces previous work pointing
to the expanding role of pharmacists in governing anti-
biotic usage, including leadership within AMS pro-
grammes internationally.15 21 Yet, these results indicate key
role-based and interprofessional issues that require atten-
tion if antibiotic stewardship roles are to be effective.22–24
Researchers have previously suggested that doctors remain
in a challenging position regarding the use of antibiotics,9
if they are required to assume all responsibility for deci-
sions about choice, dosage, duration, in addition to being
often under-informed about antibiotics in contexts where
antibiotic choice is perceived as a peripheral rather than
core clinical decision. Pharmacists are well placed to con-
tribute to decision-making and to enhance optimisation of
antibiotic practice.22
This data indicates that to enact signiﬁcant change in
hospital antibiotic prescribing, there is a need for a shift
in relations between doctors and pharmacists. As has
been shown elsewhere, pharmacy increasingly occupies
the perceived role of ‘antibiotic police’ rather than stew-
ards or advisors.23 24 Our ﬁndings support those of
other studies highlighting the limitations imposed by
such dynamics and the need to reposition the contribu-
tions of pharmacy in positive interprofessional terms.
Collaborative decision-making around antibiotics, with
direct contact between senior doctors (ie, those making
the ultimate treatment decisions) in clinical situations of
uncertainty or ambiguity, may facilitate improved rela-
tionships and capacity to advise and add-value to anti-
biotic prescribing. Without these higher-level relations,
the hierarchical nature of hospital medicine will prevent
signiﬁcant inﬂuence by pharmacy in processes of
improving antibiotic prescribing. Enhancing the role of
pharmacists in antibiotic decision-making would in turn
function to ease pressures on medical staff, with existing
well-documented problems around ongoing suboptimal
dosage and duration of antibiotics in Australian hospitals
well within pharmacy’s remit to streamline.10
The study also reinforces the need for a renewed
emphasis on promoting awareness of antibiotic use and
the proliferation of resistance across different health
professional groups, as previously identiﬁed by other
researchers.25 Consistent with their observation that the
effective dissemination of the multifaceted costs asso-
ciated with inappropriate antibiotic use remains challen-
ging, our ﬁndings conﬁrm levels of awareness and
responsiveness perceived as low in day-to-day clinical
work. This is despite the fact that this study was con-
ducted in hospitals with an active AMS programme. If
awareness of antibiotic resistance and its signiﬁcance
remains low, motivation to enact change in use will also
remain low. Equally, if the self-perceived ineffectiveness
on the part of pharmacists in inﬂuencing antibiotic pre-
scribing persists, motivation to participate in antimicro-
bial stewardship activities will also remain low.
Our study has various limitations related to research
design that need to be acknowledged. The sample size,
while appropriate for a qualitative study, is limited to the
accounts of a relatively small group of pharmacists
within these two hospital settings. Further, cross-
institutional research should be undertaken, with
national and international comparative samples. These
pharmacists’ accounts may in turn be shaped by the
organisational or cultural context of the setting, and
therefore, generalisability is limited. However, we argue
that this limitation is outweighed by the nuanced
accounts emergent from this qualitative design; accounts
which can inform AMS policy and institutional design.
Future research would beneﬁt by including other sites
and exploring other professional perspectives, and utilis-
ing group-based designs to capture dynamics across
individuals.
CONCLUSION
Antimicrobial resistance poses one of the most signiﬁ-
cant public health threats of the 21st Century7 and pro-
moting awareness and enhanced involvement in
optimisation across the range of health professionals is
required for antibiotic options to be protected for future
generations. AMS programmes taking into account inter-
professional relationships between pharmacists and
doctors, and acknowledging the inﬂuence of profes-
sional hierarchies, are likely to be more effective in
enacting lasting change.
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